IDWeek 2026
| Title: | SCY-247, a novel phase 2 IV/oral triterpenoid antifungal |
| Session: | New Antimicrobials in the Pipeline |
| Date: | Friday, October 23, 2026 at 8:00 a.m. Eastern time |
| Location: | 206 |
| Speaker: | David Angulo, M.D., President and Chief Executive Officer |